RDP58, a novel immunomodulatory peptide with anti-inflammatory effects. A pharmacological study in trinitrobenzene sulphonic acid colitis and Crohn disease. [electronic resource]
Producer: 20031021Description: 526-32 p. digitalISSN:- 0036-5521
- Adolescent
- Adult
- Aged
- Animals
- Anti-Inflammatory Agents -- pharmacology
- Colitis -- chemically induced
- Crohn Disease -- drug therapy
- Female
- Histocompatibility Antigens Class I -- pharmacology
- Humans
- Interferon-gamma -- biosynthesis
- Interleukin-1 -- biosynthesis
- Intestinal Mucosa -- drug effects
- Male
- Middle Aged
- Models, Animal
- Peptides -- pharmacology
- Prospective Studies
- Rats
- Rats, Sprague-Dawley
- Trinitrobenzenesulfonic Acid
- Tumor Necrosis Factor-alpha -- biosynthesis
No physical items for this record
Publication Type: Clinical Trial; Evaluation Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.